000			01426 a2200409 4500
005			20250513201208.0
264		0	_c20000202
008			200002s 0 0 eng d
022			_a0148-396X
040			_aNLM _beng _cNLM
100	1		_aMcAllister, L D
245	0	0	_aCognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma. _h[electronic resource]
260			_bNeurosurgery _cJan 2000
300			_a51-60; discussion 60-1 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAntimetabolites, Antineoplastic _xtherapeutic use
650	0	4	_aBlood-Brain Barrier
650	0	4	_aBrain Neoplasms _xdrug therapy
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aLymphoma _xdrug therapy
650	0	4	_aMale
650	0	4	_aMethotrexate _xadministration & dosage
650	0	4	_aMiddle Aged
650	0	4	_aNeuropsychological Tests
650	0	4	_aProspective Studies
650	0	4	_aRemission Induction
650	0	4	_aTime Factors
700	1		_aDoolittle, N D
700	1		_aGuastadisegni, P E
700	1		_aKraemer, D F
700	1		_aLacy, C A
700	1		_aCrossen, J R
700	1		_aNeuwelt, E A
773	0		_tNeurosurgery _gvol. 46 _gno. 1 _gp. 51-60; discussion 60-1
999			_c10582408 _d10582408